TEST DIRECTORY

COMMENT

The purpose of this study is to analyze BRAF gene V600E mutations, EGFR gene mutation, HER2（ERBB2 gene mutations, ALK fusion gene, ROS1 fusion gene, and RET fusion gene in genomic DNA and RNA extracted from cancer tissues to determine the indications for the drugs listed in the attached table for patients with non-small cell lung cancer.
Available for pickup is Monday-Friday.
Please make sure that the material contains the tumor site before submitting it.
Please avoid duplicate requests of other items. Since this test method is more susceptible to contamination, please handle the specimens with care when collecting them.
When requesting this test, please be sure to also request the nucleic acid extraction item (item code No.: M961 0).
●About materials other than tissues
Please place the collected pleural fluid, alveolar lavage fluid, and bronchial lavage fluid for abrasion in the designated container (ARR), centrifuge (760G (2000-3000rpm) x 10 minutes) at room temperature, remove as much of the supernatant as possible, and submit the sediment after freezing it.
●Notes
After collecting the specimen, please process it immediately. Please note that if the number of cells in the submitted specimen is low, the test may not be possible.

supplementary information

2023/8/14→梅津

2023/8/14

2023/8/14

2023/8/14

2023/8/14

2023/8/14

2023/8/14

2023/8/14

2023/8/14

2023/8/14

2023/8/14

2023/8/14

2023/8/14

2023/8/14

未確認